Opinion

Achieve Life Sciences Stock Rises on Expedited Review of E-Cig Dependence Treatment

Achieve Life Sciences Stock Rises on Expedited Review of E-Cig Dependence Treatment Achieve Life Sciences shares jumped after the company said it got a priority voucher for its treatment of nicotine ...

Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation

Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review PathwayOne of Only Nine ...